Sickle cell anemia is a genetic disorder caused by a mutation in the HBB gene, which encodes the beta-globin subunit of hemoglobin.
This mutation leads to the production of abnormal hemoglobin known as hemoglobin S (HbS).
Under low oxygen conditions, HbS can polymerize, causing RBCs to become rigid and sickle shaped.
These misshapen cells can block blood flow and break down prematurely, leading to anemia and other complications.
Pathophysiology of Sickle cell anemia
The mutation in the HBB gene results in the substitution of valine for glutamic acid at the sixth position of the beta-globin chain.
This single amino acid change causes HbS to polymerize when deoxygenated, distorting the RBCs into a sickle shape.
These sickle cells are less flexible and can block small blood vessels, leading to tissue ischemia and pain.
They also have a shorter lifespan (10-20 days) compared to normal RBCs (about 120 days), leading to chronic hemolytic anemia.
Symptoms
Symptoms of sickle cell anemia vary in severity and can include:
Anemia: Fatigue, pallor, and shortness of breath due to chronic hemolysis.
Pain Crises (Vaso-occlusive Crises): Severe pain episodes due to blockage of blood flow in small blood vessels.
Swelling: Hands and feet swelling (dactylitis) in infants and young children.
Frequent Infections: Increased susceptibility to infections due to spleen dysfunction.
Delayed Growth and Puberty: In children and adolescents.
Jaundice: Yellowing of the skin and eyes due to hemolysis.
Complications: Stroke, acute chest syndrome, pulmonary hypertension, organ damage, and leg ulcers.
Diagnosis
Sickle cell anemia is diagnosed through:
Hemoglobin Electrophoresis: Identifies the presence of HbS.
Blood Smear: Shows characteristic sickle-shaped RBCs.
Newborn Screening: Routinely performed in many countries.
Genetic Testing: Confirms mutations in the HBB gene.
Treatment
Treatment focuses on managing symptoms, preventing complications, and addressing underlying causes:
Pain Management: Analgesics, hydration, and sometimes opioids for severe pain crises.
Hydroxyurea: Increases fetal hemoglobin (HbF) levels, reducing the frequency of pain crises and other complications.
Blood Transfusions: Used to treat severe anemia and prevent complications like stroke.
Bone Marrow Transplant: Potential cure but associated with significant risks and is not suitable for all patients.
Preventive Measures: Vaccinations, prophylactic antibiotics, and regular health check-ups.
Gene Therapy: Emerging treatment with potential for curing the disease.